N/A
Manufactured by Amneal Pharmaceuticals LLC
11 FDA adverse event reports analyzed
Last updated: 2026-04-15
HYOSCYAMUS NIGER is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Amneal Pharmaceuticals LLC. The most commonly reported adverse reactions for HYOSCYAMUS NIGER include ABNORMAL BEHAVIOUR, AGITATION, ATAXIA, DELIRIUM, DISORIENTATION. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for HYOSCYAMUS NIGER.
Out of 1 classified reports for HYOSCYAMUS NIGER:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 11 FDA FAERS reports that mention HYOSCYAMUS NIGER. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include ABNORMAL BEHAVIOUR, AGITATION, ATAXIA, DELIRIUM, DISORIENTATION, DRUG INTERACTION. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Amneal Pharmaceuticals LLC in connection with HYOSCYAMUS NIGER. Always verify the specific product and NDC with your pharmacist.